Hoxworth Donor Centers closing for winter storm
February 2, 2022
Due to the predicted winter storm, Hoxworth Blood Center will close all Neighborhood Donor Centers and Blood Drives on Thursday, February 3.
Reuters Health: Study examines psychotherapy's role in intervention for BPD
December 27, 2021
Reuters Health featured the University of Cincinnati's Dr. Maria Espinola in an article examining a recent study on the use of psychotherapy when treating young people with borderline personality disorder.
55KRC: Grants aid UC research of pediatric brain tumors
March 14, 2022
55KRC featured the University of Cincinnati's Dr. Timothy Phoenix on the Simply Medicine program, discussing his research into treatments for diffuse midline glioma, a deadly pediatric brain tumor.
‘I can focus on how best I can give back’
July 19, 2022
Sushruth Muthuluru, a graduate of duPont Manual High School in Louisville, Kentucky, is an incoming Cincinnatus Presidential Scholar who has already conducted four years of medical research.
How a compound becomes a drug
July 11, 2022
Over decades of ups and downs, the hard work of University of Cincinnati alumnus John Drach paid off when the FDA approved a new drug he helped develop to treat cytomegalovirus.
Batisky named associate dean for admissions at the College of Medicine
October 3, 2022
Donald Batisky, MD, has been named associate dean for medical student admissions and special programs at the College of Medicine
UC Brain Tumor Center hosts Clinical Research Retreat
October 6, 2022
The University of Cincinnati Brain Tumor Center (BTC) held its second-annual Clinical Research Retreat on Sept. 30, bringing researchers from around the country together to discuss advancements in neuro-oncology clinical research.
Medical students mentor area school children
November 21, 2022
UC medical students mentor local school children through the Med Mentors program.
Using bacteria to target cancer treatment
March 28, 2023
Researchers led by the University of Cincinnati's Nalinikanth Kotagiri, PhD, have published new research showing proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.